Predict your next investment

HEALTHCARE | Biotechnology
cellectivedx.com

See what CB Insights has to offer

Competitors

20

CELLective Dx Corporation Competitors & Alternatives

20 Competitors

CELLective Dx Corporation has 20 competitors. CELLective Dx Corporation's competitors are AGC Biologics, Vitatex, Keryx Biopharmaceuticals, ARIAD Pharmaceuticals, Vermillion and more.

Latest Funding

Companies

Investment Stage

Total Funding

Mosaic
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

Location

9/30/2020

Acquired

Italy

8/8/2019

Acquired

New York

6/28/2018

Acq - P2P

$47M

Massachusetts

2/17/2017

Acq - P2P

Massachusetts

5/20/2015

PIPE - II

$53.35M

California

3/18/2014

TheraVasc

Unattributed VC - II

$5.72M

Ohio

10/1/2013

Onyx Pharmaceuticals

Acq - P2P

$10M

California

4/3/2012

aFraxis

Debt - III

$4.7M

California

3/29/2012

Merrimack Pharmaceuticals

IPO

$133.3M

Massachusetts

2/5/2010

Arcxis Biotechnologies

Series C - II

$8.5M

California

Latest Funding

9/30/2020

8/8/2019

6/28/2018

2/17/2017

5/20/2015

3/18/2014

10/1/2013

4/3/2012

3/29/2012

2/5/2010

Companies

TheraVasc

Onyx Pharmaceuticals

aFraxis

Merrimack Pharmaceuticals

Arcxis Biotechnologies

Investment Stage

Acquired

Acquired

Acq - P2P

Acq - P2P

PIPE - II

Unattributed VC - II

Acq - P2P

Debt - III

IPO

Series C - II

Total Funding

$47M

$53.35M

$5.72M

$10M

$4.7M

$133.3M

$8.5M

Mosaic

Location

Italy

New York

Massachusetts

Massachusetts

California

Ohio

California

California

Massachusetts

California

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.